[EN] DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE<br/>[FR] DÉGRADATION D'EGFR PAR CONJUGAISON D'INHIBITEURS D'EGFR AVEC UN LIGAND DE LIGASE E3 ET PROCÉDÉS D'UTILISATION
申请人:BEIGENE LTD
公开号:WO2022012622A1
公开(公告)日:2022-01-20
Disclosed herein are novel bifunctional compounds formed by conjugating EGFR inhibitor moieties with E3 ligase ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof.
本文披露了一种新型的双功能化合物,由EGFR抑制剂基团与E3连接酶配体基团结合而成,其功能是将靶向蛋白质招募至E3泛素连接酶进行降解,以及其制备方法和用途。